Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current immunosuppression in liver transplantation.

Stanley Martin Cohen1

  • 1Liver Study Unit, University of Chicago Medical Center, Chicago, Illinois 60637, USA. mcohen@medicine.bsd.uchicago.edu.

American Journal of Therapeutics
|March 19, 2002
PubMed
Summary

Effective immunosuppressive drugs are key to the success of liver transplantation for end-stage liver disease. This review covers the immunosuppressive agents critical for liver transplant outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A standardized scoring system for conflict of interest determination and mitigation for AASLD-sponsored continuing medical education events.

Hepatology (Baltimore, Md.)·2023
Same author

Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.

PloS one·2023
Same author

Post-Liver Transplant Lymphoproliferative Disorder Presenting as Biliary Stricture.

ACG case reports journal·2021
Same author

Drug-Induced Liver Injury from Statins.

Clinics in liver disease·2019
Same author

Dyspnea in Hepatocellular Carcinoma.

Gastroenterology·2019
Same author

Alcoholic Liver Disease.

Clinics in liver disease·2016

Area of Science:

  • Immunology
  • Hepatology
  • Transplantation Medicine

Background:

  • Liver transplantation has advanced from experimental to a standard treatment for end-stage liver disease.
  • The efficacy of liver transplantation is significantly dependent on managing immune rejection.
  • Immunosuppressive therapy is central to the success of modern liver transplant procedures.

Purpose of the Study:

  • To provide a comprehensive overview of immunosuppressive agents used in liver transplantation.
  • To highlight the role of immunosuppression in the success of liver transplant procedures.
  • To serve as a resource for understanding the pharmacological agents used post-liver transplant.

Main Methods:

  • Review of current literature on immunosuppressive agents in liver transplantation.

Related Experiment Videos

  • Analysis of the mechanisms of action and clinical applications of various immunosuppressants.
  • Synthesis of information regarding the evolution and impact of immunosuppressive regimens.

    • Main Results:

    • Identification of key immunosuppressive drug classes utilized in liver transplantation.
    • Discussion of the benefits and challenges associated with different immunosuppressive strategies.
    • Emphasis on the critical role of these agents in preventing graft rejection and improving patient survival.

    Conclusions:

    • The development of effective immunosuppressive agents has been pivotal in establishing liver transplantation as a successful therapy.
    • A thorough understanding of immunosuppressive regimens is essential for optimizing outcomes in liver transplant recipients.
    • Continued research into novel immunosuppressants may further enhance the long-term success of liver transplantation.